Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus

Kiyoshi Migita,Yukihiro Akeda,Manabu Akazawa,Shigeto Tohma,Fuminori Hirano,Haruko Ideguchi,Ryutaro Matsumura,Eiichi Suematsu,Tomoya Miyamura,Shunsuke Mori,Takahiro Fukui,Yasumori Izumi,Nozomi Iwanaga,Hiroshi Tsutani,Kouichirou Saisyo,Takao Yamanaka,Shiro Ohshima,Takao Sugiyama,Yojiro Kawabe,Masao Katayama,Yasuo Suenaga,Akira Okamoto,Hisaji Ohshima,Yasumasa Okada,Kenji Ichikawa,Shigeru Yoshizawa,Kenji Kawakami,Toshihiro Matsui,Hiroshi Furukawa,Kazunori Oishi

Pneumococcal polysaccharide vaccination in rheumatoid arthritis patients receiving tacrolimus

2015

Introduction In rheumatoid arthritis (RA) patients receiving immunosuppressive treatments, vaccination against Streptococcus pneumoniae is recommended. The objective of the study was to evaluate the effects of tacrolimus (TAC) on immune response following administration of a 23-valent pneumococcal polysaccharide vaccine (PPSV23) in patients with established RA.

Keywords:

Immunology
Rheumatoid arthritis
Abatacept
Tacrolimus
Immune system
Rheumatology
Vaccination
Medicine
Methotrexate
Pneumococcal polysaccharide vaccine
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations